Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families.

BMC cancer - 8 Mar 2012

Fernández-Rodríguez Juana, Quiles Francisco, Blanco Ignacio, Teulé Alex, Feliubadaló Lídia, Valle Jesús Del, Salinas Mónica, Izquierdo Angel, Darder Esther, Schindler Detlev, Capellá Gabriel, Brunet Joan, Lázaro Conxi, Pujana Miguel Angel

Abstract excerpt

BACKGROUND: Genes that, when mutated, cause Fanconi anemia or greatly increase breast cancer risk encode for proteins that converge on a homology-directed DNA damage repair process. Mutations in the SLX4 gene, which encodes for a scaffold protein involved in the repair of interstrand cross-links, have recently been identified in unclassified Fanconi anemia patients. A mutation analysis of SLX4 in German or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Family

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Germ-Line Mutation

Share to Introns

Share to Mutation, Missense

Share to Recombinases

Source

Open in PubMed Open full text

Identifiers

PMID: 22401137
DOI: 10.1186/1471-2407-12-84
PMCID: PMC3315397

Genes

SLX4
BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of SLX4/FANCP in non-BRCA1/2-mutated breast cancer families.PMID 22401137Read ↗

Low prevalence of SLX4 loss-of-function mutations in non-BRCA1/2 breast and/or ovarian cancer families.Semantic proximity Read ↗

Mutation analysis of the SLX4/FANCP gene in hereditary breast cancer.Semantic proximity Read ↗

Analysis of the novel fanconi anemia gene SLX4/FANCP in familial breast cancer cases.Semantic proximity Read ↗

Sequencing analysis of SLX4/FANCP gene in Italian familial breast cancer cases.Semantic proximity Read ↗

Assessment of SLX4 Mutations in Hereditary Breast Cancers.Semantic proximity Read ↗

Whole exome sequencing reveals uncommon mutations in the recently identified Fanconi anemia gene SLX4/FANCP.Semantic proximity Read ↗

Identification of low-penetrance alleles, genetic modifiers and mutation analysis in familial breast cancer casesSemantic proximity Read ↗

Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.Semantic proximity Read ↗

Mutations of the SLX4 gene in Fanconi anemia.Semantic proximity Read ↗

SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype.Semantic proximity Read ↗

Evaluation of rare variants in the new fanconi anemia gene ERCC4 (FANCQ) as familial breast/ovarian cancer susceptibility alleles.Semantic proximity Read ↗

Mutation analysis of the SHFM1 gene in breast/ovarian cancer families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.